innerbuddies gut microbiome testing

Gut Microbiome and Endometriosis: How Your Microbiome Influences Symptoms

Endometriosis is more than pelvic pain—it’s a whole-body inflammatory condition influenced by hormones, immunity, and the gut ecosystem. Emerging research suggests your gut microbiome (the trillions of microbes in your intestines) can affect the severity and timing of symptoms by shaping inflammation levels, immune signaling, and even how your body processes estrogen.

When the gut microbiome is out of balance (often called dysbiosis), it may contribute to a “pro-inflammatory” environment. This can amplify pain sensitivity, disrupt gut barrier function, and increase immune activation—factors that frequently overlap with endometriosis flares. Additionally, gut microbes play a key role in hormone metabolism, including the breakdown and recycling of estrogens through pathways linked to bile acids and enterohepatic circulation.

The good news: while microbiome research is still evolving, improving gut health can be a supportive strategy. By targeting inflammation, supporting barrier integrity, and encouraging beneficial microbes through diet and lifestyle, you may help create conditions that support immune balance and more stable hormone signaling—potentially easing symptom intensity for some people.

Get Your Gut Microbiome Test for Endometriosis Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Endometriosis

Endometriosis is an inflammatory condition in which tissue similar to the lining of the uterus grows outside it, often causing pelvic pain, bloating, and GI symptoms. Emerging evidence shows that the gut microbiome can shape how strongly the body drives inflammation, how the immune system responds, and how estrogen-related signaling is regulated—three major drivers of endometriosis symptoms. When gut balance shifts (dysbiosis) and gut barrier function is compromised, inflammatory signaling can rise and flare-ups often intensify around hormonal changes.

Microbes influence hormone handling through the estrobolome, a network of gut organisms and enzymes that metabolize estrogen metabolites. If these microbes are less efficient, more bioactive estrogen can circulate, potentially sustaining symptoms. Dysbiosis can also reduce short-chain fatty acid (SCFA) production, weakening barrier integrity and skewing immune regulation toward inflammation. Additionally, microbial metabolites and bile-acid signaling (FXR/TGR5) can modulate gut inflammation, tying endocrine dynamics to immune tone. Practical gut-support strategies—like increasing fiber variety, diversifying plant foods, and addressing constipation or bloating—aim to support a resilient microbiome and reduce inflammatory flare intensity.

Testing the gut microbiome can help clarify whether dysbiosis contributes to stronger immune activation and altered estrogen handling, guiding more targeted nutrition and lifestyle interventions. Programs like InnerBuddies translate these insights into personalized steps by assessing estrobolome capacity, identifying whether the gut environment supports immune tolerance, and recommending fiber- and stool-regularity–focused changes to promote SCFA production and barrier health for symptom stability.

  • Reduced abundance of butyrate-producing bacteria (e.g., Faecalibacterium prausnitzii, Roseburia, Eubacterium rectale, Butyrivibrio, Coprococcus) lowers SCFA levels, weakens gut barrier, and can amplify endometriosis-related inflammation.
  • Dysbiosis with enrichment of pro-inflammatory taxa (Escherichia coli and Enterobacteriaceae, Streptococcus, Bacteroides fragilis group, Prevotella, Fusobacterium, Ruminococcus gnavus, Proteobacteria) is linked to increased immune activation and symptom flares.
  • Declines in mucosal/beneficial taxa such as Akkermansia muciniphila, Bifidobacterium spp., and Lactobacillus spp. may compromise barrier integrity and dysregulate estrogen metabolism via the estrobolome.
  • The estrobolome—gut microbes that metabolize estrogens—can influence circulating bioactive estrogen; impaired estrogen handling may contribute to cyclical symptom persistence in endometriosis.
  • SCFA-producing pathways support immune tolerance and barrier function; increasing diverse, fiber-rich intake can support these microbes and potentially reduce inflammation.
  • Gut microbiome testing can guide personalized nutrition by revealing estrobolome capacity and SCFA potential, helping tailor strategies to reduce flare intensity.
Get Your Gut Microbiome Test for Endometriosis Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Endometriosis

Endometriosis is an inflammatory condition in which tissue similar to the lining of the uterus grows outside it, often triggering pelvic pain, bloating, and GI symptoms. Increasing evidence suggests that the gut microbiome can shape how strongly the body fuels inflammation, how the immune system responds, and how estrogen-related signaling is regulated—three key drivers of endometriosis symptoms. In many people, shifts in gut microbial balance (often described as “dysbiosis”) are associated with higher inflammatory signaling and altered gut barrier function, which may make flare-ups feel more intense.

Your gut bacteria also influence hormone balance through the “estrobolome,” a collection of microbes and microbial enzymes that help metabolize and recycle estrogens. If gut microbes are less efficient at breaking down or rebalancing estrogen metabolites, more bioactive estrogen may circulate, potentially contributing to symptom persistence or worsening. Microbiome changes can further affect immune regulation by influencing metabolites like short-chain fatty acids (SCFAs), which help maintain immune tolerance and gut barrier integrity. When barrier function is compromised, bacterial components may more easily interact with the immune system, amplifying inflammation that can overlap with pelvic pain.

Practical gut-support strategies—such as prioritizing a fiber-rich diet, diversifying plant foods, and using targeted approaches to reduce constipation, bloating, or dysbiosis-related symptoms—may help create a more resilient microbial community. While microbiome modulation is not a cure on its own, it can be a meaningful part of a broader, individualized plan to support inflammation control and symptom management. If you have endometriosis, focusing on gut health can be especially relevant when gastrointestinal symptoms and flare patterns suggest an inflammatory “gut–immune” connection.

  • Pelvic pain and cramping (often worsens around menstruation)
  • Chronic low back pain or pain with bowel movements
  • Bloating, constipation, diarrhea, or other gut irregularity
  • Inflammation-related flare-ups (systemic discomfort and sensitivity)
  • Painful intercourse (dyspareunia) or pain triggered by activity
  • Heavy or irregular menstrual bleeding
  • Fatigue and low energy levels
  • Hormonal imbalance symptoms (e.g., mood changes, headaches, sleep disruption)
Get Your Gut Microbiome Test for Endometriosis Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Endometriosis

This is relevant for people with endometriosis—especially those whose symptoms include prominent gut or “gut–immune” patterns. If you notice GI symptoms like bloating, constipation/diarrhea, gas, or pain during bowel movements alongside pelvic pain and cramping (often worsening around menstruation), you may be more likely to benefit from a gut-focused approach that supports inflammation control and immune regulation.

It’s also relevant for individuals who suspect their symptom flare-ups track with microbiome-related triggers, such as diet changes, antibiotic use, constipation, or periods of high stress. People who feel more systemic inflammation during flares (fatigue, heightened sensitivity, low energy) and who experience overlapping bowel and pelvic discomfort may find value in strategies that promote a resilient gut environment, including fiber-rich, diverse plant intake and targeted steps to reduce dysbiosis-associated symptoms.

This can be especially helpful for those concerned about hormone-related drivers of persistent symptoms, including heavy or irregular bleeding, mood changes, headaches, or sleep disruption. Because gut microbes participate in estrogen processing through the “estrobolome,” individuals with ongoing estrogen-related symptom patterns—along with GI symptoms—may want to consider gut health as part of a broader, individualized plan to support more balanced estrogen metabolite circulation and healthier barrier/immune function.

Endometriosis is a common hormone-driven inflammatory condition. In people of reproductive age, it affects an estimated ~10% (about 1 in 10), which is why it is widely regarded as one of the most prevalent gynecologic disorders. Because symptoms often fluctuate and overlap with GI issues, many cases go unrecognized, meaning real-world prevalence may be higher in practice than in diagnosed records.

While prevalence varies by study design and diagnostic method, global estimates consistently cluster around the same order of magnitude (~6–10% of reproductive-age individuals). Among those seeking care for pelvic pain or suspected gynecologic causes, the proportion is notably higher; for example, studies of chronic pelvic pain cohorts often report endometriosis in roughly 20–40% of patients, reflecting the strong link between endometriosis and pelvic pain and related inflammatory symptoms.

The condition also shows a meaningful association with symptoms that overlap the gut–immune axis. People with endometriosis frequently report GI irregularities—such as constipation, diarrhea, and bloating—along with fatigue, painful bowel movements, and symptom worsening around menstruation. Although symptom prevalence differs across cohorts, these common patterns contribute to both delayed diagnosis and the high clinical burden, reinforcing that endometriosis remains a widespread condition affecting a substantial share of individuals who menstruate.

Get Your Gut Microbiome Test for Endometriosis Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Gut Microbiome & Endometriosis: How Your Microbiome Influences Symptoms

Endometriosis is an inflammatory disorder, and growing evidence suggests the gut microbiome can influence how strongly the immune system drives (and amplifies) symptoms. When gut microbial balance is disrupted (“dysbiosis”), changes in inflammation signaling and reduced gut barrier integrity may allow bacterial components and inflammatory cues to interact more easily with the immune system. That can intensify pelvic pain, bloating, and other GI-related symptoms—especially during hormonal shifts that often trigger flares.

Microbes also affect estrogen handling through the “estrobolome,” a network of gut organisms and microbial enzymes that metabolize and recycle estrogen metabolites. If certain microbes are less effective at breaking down or rebalancing estrogen byproducts, more bioactive estrogen may circulate, potentially supporting symptom persistence or worsening. This microbiome–hormone connection may help explain why endometriosis symptoms (including fatigue, menstrual irregularity, and sensitivity that rises around periods) can track with changes in gut function.

Dietary and microbial metabolites can further shape immune regulation and gut–immune communication. Short-chain fatty acids (SCFAs), generated when beneficial bacteria ferment fiber, help support gut barrier integrity and immune tolerance—processes that may protect against inflammatory overreaction. When constipation, diarrhea, or bloating disrupt stool regularity and fermentation patterns, it can be harder to maintain SCFA production and a stable barrier. Practical gut-support strategies (like increasing fiber variety, diversifying plant foods, and addressing bowel irregularity) may therefore complement broader endometriosis management by promoting a more resilient microbiome and reducing inflammation-related flare intensity.

Get Your Gut Microbiome Test for Endometriosis Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Gut Microbiome and Endometriosis

  • Dysbiosis-driven immune amplification: Gut microbial imbalance can alter inflammatory signaling, making immune responses more reactive and intensifying pelvic pain and GI symptoms in endometriosis.
  • Reduced gut barrier integrity: Dysbiosis can weaken tight junctions and barrier function, allowing bacterial components (e.g., LPS) and inflammatory cues to more easily trigger systemic immune activation.
  • Shifted microbial metabolite balance (SCFAs): Lower fiber-fermenting/beneficial bacteria can reduce short-chain fatty acids that normally support gut barrier integrity and immune tolerance, promoting inflammation and flare susceptibility.
  • Estrobolome effects on estrogen recycling: Specific gut organisms and enzymes metabolize and recycle estrogen metabolites; dysbiosis may impair estrogen clearance/rebalancing, increasing bioactive estrogen that can sustain or worsen symptoms.
  • Hormone–microbiome feedback loops: Hormonal shifts around menstrual cycles can change gut microbial composition and function, which then modulates immune tone and symptom severity.
  • Microbial regulation of gut–immune communication: Changes in microbial metabolites and signaling (including bile acid and indole derivatives) can influence immune pathways (e.g., Treg/Th17 balance), affecting inflammatory persistence.
  • Altered bile acid metabolism and inflammation: Dysbiosis can change bile acid pools and receptor signaling (e.g., FXR/TGR5 pathways), which can affect both gut inflammation and systemic immune regulation.

In endometriosis, a key emerging theme is that gut microbiome disruption (“dysbiosis”) can intensify immune activity rather than keeping inflammation well-regulated. When microbial communities shift, inflammatory signaling can become more reactive, so immune pathways respond more strongly to gut-derived cues. At the same time, dysbiosis can weaken the intestinal barrier by altering tight junctions, making it easier for microbial components (such as LPS) and inflammatory molecules to cross into areas where they can trigger systemic immune activation. Together, these effects can help explain why pelvic pain and GI symptoms like bloating may flare more intensely—particularly during hormonal transitions that already stress immune balance.

Microbes also influence endometriosis through their metabolic byproducts. Beneficial bacteria ferment dietary fiber to produce short-chain fatty acids (SCFAs), including butyrate, which help support a healthy gut barrier and promote immune tolerance. If dysbiosis reduces fiber-fermenting bacteria, SCFA levels may fall, reducing barrier protection and tipping immune regulation toward a more inflammatory state. In parallel, microbial metabolites involved in signaling (including pathways tied to Treg/Th17 balance) can further affect how persistently inflammation is maintained, creating a feedback loop where gut symptoms and immune sensitivity reinforce each other.

Finally, the microbiome may contribute to hormone-related symptom persistence via the “estrobolome,” the collection of gut organisms and enzymes that metabolize and recycle estrogen metabolites. If dysbiosis impairs the microbes responsible for breaking down or rebalancing estrogen byproducts, more bioactive estrogen may circulate, potentially supporting symptom maintenance or worsening around the menstrual cycle. Hormonal shifts can also reshape the gut ecosystem itself, altering microbial composition and metabolite production, which then affects immune tone and gut–immune signaling. Additional dysbiosis-related changes in bile acid composition and receptor signaling (such as FXR and TGR5) can further modulate gut inflammation and systemic immune pathways, linking microbial balance, inflammatory activity, and endocrine dynamics in endometriosis.

Get Your Gut Microbiome Test for Endometriosis Get Your Gut Microbiome Test Subscription
innerbuddies gut microbiome testing

Microbial patterns summary

In endometriosis, research commonly points to gut microbial dysbiosis, where the normal community balance is shifted in ways that can increase inflammatory reactivity. When microbial signaling becomes less well-regulated, the immune system may respond more strongly to gut-derived stimuli, contributing to intensified pelvic pain and gastrointestinal symptoms such as bloating—often during hormonal transitions that already stress immune balance. Alongside these functional changes, dysbiosis can alter intestinal barrier integrity, weakening tight junctions so that bacterial components and inflammatory cues cross more easily, amplifying systemic immune activation.

Metabolically, endometriosis-associated dysbiosis is frequently discussed in relation to reduced production of key microbial metabolites that normally support immune tolerance and barrier health. Beneficial, fiber-fermenting bacteria generate short-chain fatty acids (SCFAs) like butyrate, which help maintain gut lining integrity and promote a more balanced Treg/immune signaling environment. When those SCFA-producing groups decline or when fermentation patterns are disrupted by low fiber intake or irregular bowel habits, SCFA levels may drop, which can impair barrier protection and tilt immune regulation toward a more pro-inflammatory state. This creates a feedback loop in which gut symptoms can further destabilize the microbiome and reinforce inflammatory tone.

A second recurring pattern involves microbiome–hormone interactions through the “estrobolome,” the community of microbes and enzymes that metabolize and recycle estrogen metabolites. In some cases, dysbiosis may reduce the efficiency of clearing or rebalancing estrogen byproducts, allowing more bioactive estrogen to persist and potentially contribute to symptom persistence or worsening around the menstrual cycle. Hormonal fluctuations themselves can also reshape the gut ecosystem, changing metabolite outputs and bile acid profiles that signal through pathways such as FXR and TGR5, which can further modulate gut inflammation and systemic immune pathways—linking endocrine dynamics, microbial metabolism, and symptom severity.


Low beneficial taxa

  • Faecalibacterium prausnitzii
  • Roseburia spp.
  • Eubacterium rectale
  • Butyrivibrio spp.
  • Coprococcus spp.
  • Bifidobacterium spp.
  • Akkermansia muciniphila
  • Lactobacillus spp.


Elevated / overrepresented taxa

  • Escherichia coli (and other Enterobacteriaceae)
  • Streptococcus spp.
  • Bacteroides fragilis group
  • Prevotella spp.
  • Fusobacterium spp.
  • Ruminococcus gnavus group
  • Proteobacteria (class-level enrichment)
  • Bacteroides spp. (enrichment patterns)


Functional pathways involved

  • Short-chain fatty acid (SCFA) biosynthesis and butyrate/propionate production (e.g., Faecalibacterium/Roseburia–associated fermentation pathways)
  • Intestinal epithelial tight-junction integrity and mucosal barrier maintenance pathways (SCFA- and mucin-linked barrier regulation)
  • Gut immune modulation via Treg/Th17 signaling shaped by microbial metabolites (tolerance vs pro-inflammatory immune skewing)
  • Bile acid metabolism and signaling (primary-to-secondary conversion affecting FXR and TGR5 immune/inflammatory pathways)
  • Estrogen metabolite recycling and the “estrobolome” (microbial deconjugation/re-association of estrogens influencing bioactive estrogen persistence)
  • Lipopolysaccharide (LPS)/bacterial component sensing pathways (e.g., TLR4/NOD-like receptor activation driven by higher Proteobacteria/Enterobacteriaceae)
  • Bacterial proteolysis and mucin degradation–associated inflammatory byproducts (connects elevated protease/mucin-utilization microbes to barrier stress)
  • Iron/heme acquisition and oxidative stress resistance pathways (commonly enriched in Enterobacteriaceae/Proteobacteria and linked to inflammatory competence)


Diversity note

In endometriosis, studies commonly describe an overall shift away from the usual gut microbial balance, with lower gut community resilience and changes in relative abundance across multiple bacterial groups. Rather than a single “one-germ” cause, the pattern often involves community-level imbalance that can make microbial signaling to the immune system less regulated. This can coincide with reduced prevalence of bacteria that normally support gut barrier maintenance and immune tolerance, alongside overrepresentation of taxa associated with inflammatory activation.

These diversity changes can also translate into functional alterations in microbial metabolism, even when total diversity appears only modestly different. For example, dysbiosis frequently associates with diminished capacity for fiber fermentation and lower production of short-chain fatty acids (SCFAs) such as butyrate, which are closely linked to epithelial tight-junction integrity and more balanced immune signaling. When the ecosystem is less able to sustain SCFA-generating pathways, gut permeability may increase and the immune system can become more reactive to microbial components, potentially amplifying bloating and pain—especially during hormone-driven flare windows.

Finally, gut microbial diversity shifts may influence the microbiome’s ability to handle estrogen metabolites through the “estrobolome.” Community-level changes can affect which microbial enzymes are available to metabolize and recycle estrogen byproducts, potentially altering circulating bioactive estrogen levels and contributing to symptom persistence or cyclical worsening. Hormonal fluctuations themselves can further reshape the gut ecosystem, creating a bidirectional loop where changing microbial diversity and metabolite output track with immune tone and symptom severity over the menstrual cycle.


Get Your Gut Microbiome Test for Endometriosis Get Your Gut Microbiome Test Subscription

Why generic solutions fail

  • Issue with generic solutions

    Generic endometriosis gut “fixes” often fail because they don’t address the specific gut–immune–hormone circuitry driving symptom flares. Endometriosis is associated with gut dysbiosis that can heighten immune responsiveness to microbial signals, weaken gut barrier integrity, and amplify inflammation. When the underlying issue is disrupted immune regulation and barrier dysfunction, approaches that only target symptoms (like reducing bloating without improving stool consistency, fermentation, or barrier support) may offer temporary relief while the inflammatory feedback loop continues—especially around hormonal transitions when the gut ecosystem becomes even more vulnerable.

    They also tend to fall short because microbiome changes are not one-size-fits-all and are strongly shaped by metabolite production, particularly short-chain fatty acids (SCFAs). Many broad dietary recommendations emphasize “more fiber” or “eat less inflammation,” but without tailoring to tolerance, bowel habits, and realistic food variety, fiber may not ferment effectively. If SCFA-producing communities and fermentation patterns don’t recover, gut barrier protection and immune tolerance (including Treg-linked signaling) may not improve, leaving patients prone to recurrent flares and persistent GI symptoms.

    Finally, generic strategies often ignore the microbiome–estrogen relationship via the “estrobolome.” If dysbiosis interferes with estrogen metabolite clearance or rebalancing, more bioactive estrogen metabolites may circulate and sustain symptom severity, particularly around menstruation. Since hormones themselves reshape gut ecology (through bile acid and signaling pathways), blanket interventions may improve one pathway briefly but not rebalance estrogen handling and immune signaling together—so symptoms can rebound despite “standard” gut-support efforts.

  • Common mistakes

    • Treating endometriosis as a generic “bloating/inflammation” issue instead of addressing the gut–immune–hormone loop (dysbiosis-driven immune hyperreactivity + barrier weakness + flare timing).
    • Pushing broad “more fiber” advice without confirming tolerance and stool/fermentation capacity—so fiber doesn’t ferment well enough to restore SCFA (e.g., butyrate) production and barrier support.
    • Overemphasizing foods or supplements aimed at symptom masking while neglecting barrier integrity drivers (e.g., tight junction health, fermentation patterns, and SCFA sufficiency), leading to temporary relief and relapse.
    • Using non-targeted probiotics/prebiotics without matching to likely deficits (e.g., SCFA-producing taxa or fermentation substrates), which can worsen gas/bloating in some patients or fail to restore immune tolerance.
    • Ignoring the estrobolome (microbial estrogen metabolite recycling/clearance) and assuming gut interventions won’t affect estrogen persistence—so symptoms rebound around menstruation despite “gut fixes.”
    • Not considering hormone-driven microbiome shifts (bile acid signaling via FXR/TGR5 and related immune modulation), resulting in plans that don’t adapt through menstrual-cycle windows when dysbiosis vulnerability is higher.
    • Assuming that dietary changes will work the same for all microbiomes—failing to individualize based on baseline microbiome function, constipation/diarrhea pattern, and real-world adherence.
    • Over-restricting or making abrupt diet changes (or using restrictive elimination diets) that reduce microbial diversity and fermentation stability, further undermining SCFA output and barrier protection.

What to do

  • General support strategies

    For endometriosis, general gut-support efforts focus on reducing inflammatory amplification and improving gut barrier function, since a dysregulated microbiome can make immune signaling more reactive and easier for bacterial or inflammatory cues to interact with the body. Supporting regular digestion and minimizing gut irritation can help maintain a more stable intestinal environment—particularly during hormonal shifts that often coincide with symptom flares. Many people benefit from emphasizing overall digestive regularity (to avoid constipation or frequent loose stools), eating in a way that supports comfortable fermentation rather than overstimulation, and choosing foods that help the gut ecosystem produce anti-inflammatory microbial metabolites.

    A central strategy is microbiome nourishment through dietary variety, especially by increasing diverse plant fibers and minimally processed plant foods. When fiber is consistently consumed, gut microbes can generate short-chain fatty acids (SCFAs) that support the integrity of the gut lining and help “calm” excessive immune responses. Because stool consistency and fermentation patterns depend on how food is broken down and moved through the GI tract, it can be helpful to gradually broaden fiber sources (while monitoring tolerance) and pair them with adequate hydration. This approach aims to promote a resilient gut barrier and more balanced immune regulation.

    Supporting estrogen handling is another key theme, given the gut’s role in metabolizing and recycling estrogen compounds through the so-called estrobolome. Diet and microbial activity can influence how efficiently estrogen metabolites are processed, which may affect symptom persistence for some individuals. In practice, improving overall gut health—through fiber diversity, gut-regularity strategies, and reducing triggers that worsen bloating or irregular bowel habits—may help the microbiome better manage hormone-related byproducts. The goal is not a single “miracle” food, but rather a pattern of nourishment that supports microbial diversity, steadier digestion, and lower inflammatory flare intensity over time.

  • Lifestyle recommendations

    • Prioritize a diverse, fiber-rich plant intake (aim for a variety of vegetables, legumes, whole grains, nuts, and seeds) to support beneficial gut bacteria and SCFA production.
    • Improve bowel regularity (address constipation or diarrhea with adequate fluids, fiber gradually, and meal timing) to help maintain gut barrier function and reduce inflammatory flare triggers.
    • Limit highly processed foods and excess added sugars, which can promote dysbiosis and worsen inflammation in some people.
    • Consider a diet pattern that reduces symptom-provoking GI triggers (common examples: lactose, alcohol, very high-fat meals, or high-FODMAP foods) using a structured elimination/reintroduction approach if needed.
    • Support hormonal stability where possible: maintain consistent sleep, physical activity, and stress-reduction habits (e.g., mindfulness, CBT, gentle yoga), since stress and hormonal shifts can amplify flares.
    • If you use supplements (e.g., fiber/prebiotics or probiotics), choose evidence-informed options and monitor symptom response; avoid starting many new products at once to identify what helps.

  • Nutrition recommendations

    • Increase dietary fiber diversity (aim for a mix of soluble and fermentable fibers from beans/lentils, oats, chia/flax, berries, and non-starchy vegetables) to support SCFA production and strengthen gut barrier function.
    • Prioritize a plant-forward, anti-inflammatory eating pattern (e.g., Mediterranean-style) with high polyphenol foods such as olive oil, nuts, seeds, berries, cocoa, turmeric/ginger, and colorful vegetables to help modulate immune signaling and dysbiosis.
    • Support regular bowel movements to improve fermentation balance (adequate water + fiber, and use stool-regularity strategies like prunes/kiwi or psyllium if tolerated) to reduce constipation-associated inflammation and symptom flares.
    • Add probiotic and/or fermented foods in tolerance (e.g., yogurt/kefir with live cultures, kimchi, sauerkraut, miso, tempeh) to promote microbiome stability—start gradually to minimize bloating.
    • Emphasize prebiotic foods while limiting highly processed, low-fiber foods (cut back on ultra-processed snacks, excess added sugars, and refined carbs) to reduce dysbiosis drivers and inflammatory cues.
    • Consider omega-3 support from diet (fatty fish like salmon/sardines 2x/week, or algae-based EPA/DHA) to help balance inflammatory pathways that can amplify pain and GI symptoms.

  • Supplement considerations

    For endometriosis, supplement strategies often focus on supporting a healthier gut–immune balance, since dysbiosis may increase inflammatory signaling and weaken gut barrier integrity—factors that can intensify pelvic pain, bloating, and other GI symptoms, particularly around hormonal shifts. In practice, supplements that promote a more resilient microbiome may help improve microbial diversity and stabilize stool patterns, which can reduce the likelihood that inflammatory bacterial components interact more easily with the immune system. Approaches may include targeted probiotics (chosen for strains with evidence in gut barrier/immune modulation), prebiotic fibers (used to feed beneficial bacteria), and adjuncts that support mucosal health and regularity—especially when constipation, diarrhea, or irregular bowel habits are present.

    Another key consideration is the “estrobolome,” the set of gut organisms and microbial enzymes involved in estrogen metabolism and recycling. Some people with endometriosis may benefit from supplements that support normal estrogen handling by encouraging microbial pathways that break down or rebalance estrogen metabolites. This is where gut microbiome–supportive nutrients can matter: adequate fiber and polyphenols can foster beneficial fermentation and metabolite production, while maintaining regular elimination can help prevent reabsorption of estrogen-related compounds. Because hormone-related flares often track with the menstrual cycle, supplement timing and consistency (rather than short-term use alone) may be important for supporting steadier symptom control.

    Metabolites such as short-chain fatty acids (SCFAs), particularly butyrate, play a major role in gut barrier integrity and immune tolerance. Supplements that help maintain SCFA production—or directly supply gut-friendly metabolites such as butyrate in appropriate forms—may be considered when fiber intake is limited or symptoms suggest barrier stress. It can also be helpful to consider nutrients involved in anti-inflammatory signaling and mucosal function (for example, magnesium for bowel regularity or omega-3–containing products for broader inflammatory modulation), while being mindful that individual tolerance varies. As always, it’s prudent to choose products with clear strain-level labeling, start low and titrate, and consult a clinician if you’re managing complex symptoms or using hormonal therapies.

  • Retesting / monitoring note

    For endometriosis, retesting is most helpful when it’s used to monitor whether gut-directed changes are actually improving microbiome balance and gut–immune function. Because gut microbial composition can shift with diet, antibiotic exposure, stress, bowel habits, and hormonal fluctuations, retesting is typically most informative after a stable intervention period (often around 8–12 weeks) rather than immediately after changes begin. If symptoms and stool patterns are especially cyclical with the menstrual cycle, aligning retesting with the same phase across cycles (or after a flare has fully settled) can improve interpretability.

    When the goal is to evaluate the gut microbiome’s role in inflammation signaling and gut barrier integrity, retesting should ideally include markers that reflect microbial activity (not just who is present). Depending on the lab approach, follow-up testing may assess functional outputs such as microbial metabolites (including SCFA-related signals), inflammatory or barrier-related readouts, and evidence of dysbiosis (e.g., altered bacterial profiles). If constipation, diarrhea, or inconsistent stool frequency is driving symptoms, retesting after addressing bowel regularity is particularly important, since stool transit time can strongly influence microbial fermentation, SCFA production, and overall immune tolerance.

    Retesting may also be considered when there are changes in estrogen-handling dynamics via the “estrobolome,” especially if symptoms persist despite broader endometriosis management. In that case, follow-up timing matters: hormonal shifts can alter microbial metabolism, so retesting should be scheduled in a way that reflects a comparable hormonal context each time. If new medications are introduced (particularly antibiotics, probiotics, laxatives, or hormone therapies), it’s usually best to wait until the microbiome has stabilized—often several weeks—before performing the next test. This helps ensure that retest results capture the ongoing effect of the intervention rather than temporary perturbations.

The importance of gut microbiome testing

  • Why testing matters

    Gut microbiome testing can matter in endometriosis because it helps clarify whether gut dysbiosis may be contributing to how strongly the immune system reacts. When microbial balance is disrupted, inflammation signaling can become amplified and the gut barrier may become less robust, making it easier for bacterial components and inflammatory cues to interact with the immune system. Since many people experience GI symptoms (like bloating or altered bowel habits) alongside pelvic pain—often worsening around hormonal shifts—understanding an individual’s microbiome profile can shed light on likely drivers of flare intensity rather than relying on symptoms alone.

    Testing also becomes relevant for the microbiome–hormone connection. The “estrobolome” describes gut organisms and enzymes that help metabolize and recycle estrogen metabolites. If certain microbial functions are underperforming, more bioactive estrogen byproducts may persist, potentially supporting symptom persistence or worsening through the menstrual cycle. By identifying patterns such as reduced beneficial estrogen-processing capacity or shifts in key metabolite-producing taxa, microbiome results can guide more targeted nutrition strategies aimed at improving estrogen handling and overall symptom stability.

    Finally, microbiome testing can inform how well the gut environment supports immune regulation—particularly through microbial metabolites like short-chain fatty acids (SCFAs). SCFAs produced from diverse, fiber-rich fermentation help maintain gut barrier integrity and support immune tolerance. If testing suggests low SCFA-supporting conditions (often linked to low fiber diversity or irregular stool patterns), it can help clinicians tailor diet and gut-regularity interventions to promote a more resilient microbiome and potentially reduce inflammation-related symptom amplification.

  • How InnerBuddies helps

    InnerBuddies can help people with endometriosis by looking beyond pelvic symptoms to the gut drivers that may influence immune activation and flare intensity. Because dysbiosis can weaken gut barrier integrity and increase the ease with which inflammatory signals are amplified, the InnerBuddies results can highlight whether your gut ecosystem looks more supportive of immune tolerance (e.g., through metabolite-producing, barrier-supporting patterns) or more prone to inflammatory overreaction. This can be especially relevant for identifying why bloating, bowel changes, and pelvic pain often track together, particularly around hormonal shifts.

    In addition, InnerBuddies can provide insight into the microbiome–hormone connection via the “estrobolome,” the community of gut microbes and microbial enzymes involved in estrogen metabolite processing. If your results suggest an underperforming profile for breaking down or rebalancing estrogen-related byproducts, this may help explain why symptoms can persist or intensify around the menstrual cycle for some individuals. Understanding these patterns can make nutrition and lifestyle guidance more personalized, targeting the specific gut conditions that may affect estrogen handling rather than guessing based on symptoms alone.

    Finally, the InnerBuddies test can support more targeted strategies by reflecting how your current gut environment supports beneficial fermentation and short-chain fatty acid (SCFA) production—key compounds linked to gut barrier health and immune regulation. If the results suggest factors that commonly reduce SCFA support (such as low diversity of fiber-fermenting microbes or signals consistent with irregular stool patterns), your plan can focus on improving gut regularity and increasing fiber variety to promote a more resilient microbiome. In practice, this helps connect test findings to actionable steps that may reduce inflammation-related symptom amplification over time.

Medical Evidence

  • Scientific evidence level

    2 [weak—mostly hypothesis-generating with limited and methodologically heterogeneous human evidence; insufficient causal and interventional proof for clinical actionability]

  • Clinical relevance note

    At present, the gut microbiome–endometriosis link is best viewed as an emerging, biologically plausible association with preclinical mechanistic support but insufficient human causal proof. The evidence does not yet meet the standard needed for clinically actionable recommendations (e.g., recommending probiotics/prebiotics or using microbiome profiling for diagnosis or severity stratification). Statistically significant associations reported in some studies should not be equated with probable causal involvement due to confounding (diet, medications, hormonal treatments, BMI, inflammatory comorbidities), reverse causality (endometriosis-related inflammation and symptoms potentially changing diet and gut physiology), and methodological inconsistency.

    Clinically, microbiome findings could eventually contribute to risk stratification, subtype characterization, or treatment monitoring, but current limitations—small sample sizes, weak external validation, mismatch between stool microbiome and relevant mucosal/lesion-associated communities, and the lack of RCTs showing durable symptom or lesion benefits—mean that the field is not yet at a validated clinical application stage. If you’re considering this evidence for practice or trials, the most evidence-aligned near-term role is hypothesis generation and careful mechanistic exploration rather than routine testing or microbiome-targeted therapy.

Title Journal Year Link
Gut microbiota alterations in endometriosis: A systematic review and meta-analysis of observational studies Frontiers in Cellular and Infection Microbiology 2023 View →
Alterations in the gut microbiome and metabolome are associated with endometriosis and endometriosis-related infertility Gut 2022 View →
The gut microbiome and endometriosis: a critical review of clinical and mechanistic evidence Microbiome 2021 View →
Fecal microbiota transplantation improves endometriosis-like lesions in a mouse model Journal of Translational Medicine 2021 View →
Metagenomic analysis reveals dysbiosis of the gut microbiome in women with endometriosis Frontiers in Microbiology 2020 View →

Frequently Asked Questions

    Qu'est-ce que l'endométriose ?
    L’endométriose est une maladie inflammatoire hormonodépendante où un tissu semblable à la muqueuse utérine se développe à l’extérieur de l’utérus, provoquant souvent des douleurs pelviennes.
    Comment le microbiote intestinal peut-il influencer les symptômes de l’endométriose ?
    Le microbiote peut affecter l’inflammation, les réponses immunitaires et le métabolisme des œstrogènes, ce qui peut influencer l’intensité des symptômes et les poussées.
    Qu’est-ce que l’estrobolome ?
    L’estrobolome est un ensemble de microbes et d’enzymes intestinaux qui métabolisent et recyclent les métabolites des œstrogènes. Si ce traitement est moins efficace, plus d’œstrogènes biologiquement actifs circulent.
    Qu’est-ce que les SCFA et pourquoi sont-ils importants ?
    Les acides gras à chaîne courte (SCFA) comme le butyrate proviennent de la fermentation des fibres et aident à maintenir la barrière intestinale et à réguler les réponses immunitaires, ce qui peut réduire l’inflammation.
    Qu’est-ce que la dysbiose intestinale ?
    La dysbiose est un déséquilibre de la microbiote intestinale, pouvant être associé à des signaux inflammatoires plus élevés et à une barrière intestinale plus faible.
    Quels symptômes peuvent indiquer l’implication intestinale dans l’endométriose ?
    Des symptômes GI (ballonnements, constipation, diarrhée) et des douleurs pelviennes qui s’aggravent autour des règles, plus de la fatigue.
    Devrais-je envisager des tests du microbiome ?
    Les tests peuvent aider à clarifier si une dysbiose ou un traitement des œstrogènes contribue aux symptômes, mais ils ne remplacent pas un diagnostic d’endométriose.
    Comment soutenir la santé intestinale par l’alimentation ?
    Adopter un régime varié et riche en fibres à base de plantes, augmenter les fibres progressivement, rester hydraté et viser une régularité intestinale.
    Y a-t-il des aliments à éviter ou à limiter ?
    Concentrez-vous sur la diversité des fibres et la régularité; les déclencheurs varient; discuter avec un médecin ou un diététicien pour identifier les sensibilités.
    Est-ce que plus de fibres peut aider la constipation ou les ballonnements ?
    Oui, une plus grande diversité de fibres et une augmentation progressive peuvent améliorer la régularité et favoriser les SCFA; boire suffisamment d’eau et surveiller la tolérance.
    Les changements du microbiome se rapportent-ils aux symptômes liés au cycle ?
    Des indices suggèrent que le microbiote et le métabolisme des œstrogènes peuvent interagir, influençant les symptômes autour de la période.
    Que peut dire un test du microbiome sur les hormones ?
    Il peut indiquer dans quelle mesure l’œstrogène est métabolisé; ce n’est pas un prédicteur unique des schémas de symptômes.
    Qu’est-ce que « InnerBuddies » et comment se rapporte-t-il à l’endométriose ?
    InnerBuddies est un test qui examine des caractéristiques du microbiome liées à l’inflammation, à la gestion des œstrogènes et à la production de SCFA pour guider des conseils nutritionnels et de mode de vie.
    Comment intégrer des stratégies de santé intestinale dans la gestion globale de l’endométriose ?
    Elles peuvent faire partie d’un plan global pour le contrôle de l’inflammation et la gestion des symptômes, en complément d’autres traitements.
    Existe-t-il une cure prouvée de l’endométriose via les changements du microbiome ?
    Non. La modulation du microbiome peut aider les symptômes, mais ce n’est pas une cure ; consultez votre professionnel de santé pour un plan de traitement global.
    Quelle est la prévalence de l’endométriose ?
    Chez les personnes en âge de procréer, on estime environ 10%; la prévalence varie selon les études.
    Que dois-je discuter avec mon médecin au sujet de la santé intestinale et de l’endométriose ?
    Parlez des symptômes GI, des schémas de poussées, des tests possibles, des changements alimentaires, de l’apport en fibres, de la régularité intestinale et de l’opportunité de tests du microbiome.

    Hear from our satisfied customers!

    • "I would like to let you know how excited I am. We had been on the diet for about two months (my husband eats with us). We felt better with it, but how much better was really only noticed during the Christmas vacations when we had received a large Christmas package and didn't stick to the diet for a while. Well that did give motivation again, because what a difference in gastrointestinal symptoms but also energy in both of us!"

      - Manon, age 29 -

    • "Super help!!! I was already well on my way, but now I know for sure what I should and should not eat, drink. I have been struggling with stomach and intestines for so long, hope I can get rid of it now."

      - Petra, age 68 -

    • "I have read your comprehensive report and advice. Many thanks for that and very informative. Presented in this way, I can certainly move forward with it. Therefore no new questions for now. I will gladly take your suggestions to heart. And good luck with your important work."

      - Dirk, age 73 -